571 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ovarian Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
3 Not yet recruiting Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: Cytoreductive Surgery (CRS);   Procedure: Hyperthermic Intraperitoneal Chemotherapy (HIPEC);   Drug: Systemic Chemotherapy
4 Recruiting A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Interventions: Drug: Rucaparib;   Drug: Placebo
5 Recruiting A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer
Condition: Ovarian Cancer, Pancreatic Cancer
Interventions: Drug: DMCU4064A;   Drug: DMUC4064A
6 Unknown  Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Cervical Cancer;   Endometrial Cancer;   Esophageal Cancer;   Fallopian Tube Cancer;   Gastric Cancer;   Ovarian Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: informational intervention;   Procedure: assessment of therapy complications;   Procedure: psychosocial assessment and care
7 Recruiting Chk1/2 Inhibitor (LY2606368) in Women With BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Non-High Risk Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer at Low Genetic Risk
Conditions: Ovarian Cancer;   Breast Cancer
Intervention: Drug: LY2606368
8 Unknown  Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Simvastatin;   Drug: Simvastatin and Metformin;   Drug: Metformin
9 Recruiting Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Carcinoma;   Peritoneal Carcinoma
Intervention: Drug: carboplatin and paclitaxel followed by surgery
10 Recruiting Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Condition: Ovarian Epithelial Cancer Recurrent
Interventions: Drug: bevacizumab and trabectedin;   Drug: bevacizumab, trabectedin and carboplatin
11 Recruiting A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Device: ThermalCore Hyperthermia System
12 Recruiting EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mixed Epithelial Carcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Undifferentiated Adenocarcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer
Interventions: Biological: EGEN-001;   Drug: pegylated liposomal doxorubicin hydrochloride;   Other: laboratory biomarker analysis
13 Recruiting Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer
Conditions: FIGO Stage IIC-IV Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Peritoneal Carcinoma
Intervention: Drug: carboplatin
14 Recruiting Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: pazopanib hydrochloride;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Recruiting Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)
Conditions: Polycystic Ovary Syndrome;   Metabolic Diseases;   Overweight
Intervention:
16 Unknown  Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome
Conditions: Anovulation;   Hyperandrogenism;   Polycystic Ovary Syndrome;   Single Nucleotide Polymorphism
Intervention:
17 Recruiting Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: NGR-hTNF;   Drug: Pegylated liposomal doxorubicin;   Drug: Doxorubicin
18 Recruiting Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
Conditions: Polycystic Ovary Syndrome (PCOS);   Menstrual Irregularity
Intervention:
19 Recruiting The Genetic Investigation of Reproductive Disorders (Including Kallmann Syndrome)
Conditions: Kallmann Syndrome;   Hypogonadotropic Hypogonadism;   Hypothalamic Amenorrhea;   Polycystic Ovarian Syndrome;   Precocious Puberty
Intervention:
20 Recruiting Sentinel Node in Ovarian Cancer
Conditions: Ovarian Cancer;   Sentinel Node
Intervention: Procedure: blue dye and radioactive tracer

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years